PL2024748T3 - Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego - Google Patents

Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego

Info

Publication number
PL2024748T3
PL2024748T3 PL07725949T PL07725949T PL2024748T3 PL 2024748 T3 PL2024748 T3 PL 2024748T3 PL 07725949 T PL07725949 T PL 07725949T PL 07725949 T PL07725949 T PL 07725949T PL 2024748 T3 PL2024748 T3 PL 2024748T3
Authority
PL
Poland
Prior art keywords
annexin
antibodies
detection
monoclonal anti
prostate carcinoma
Prior art date
Application number
PL07725949T
Other languages
English (en)
Inventor
André Schrattenholz
Original Assignee
Proteosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteosys Ag filed Critical Proteosys Ag
Publication of PL2024748T3 publication Critical patent/PL2024748T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL07725949T 2006-06-09 2007-06-11 Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego PL2024748T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US85948906P 2006-11-17 2006-11-17
PCT/EP2007/005134 WO2007141043A2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma
EP07725949A EP2024748B1 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma

Publications (1)

Publication Number Publication Date
PL2024748T3 true PL2024748T3 (pl) 2013-05-31

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07725949T PL2024748T3 (pl) 2006-06-09 2007-06-11 Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego

Country Status (13)

Country Link
US (1) US8012697B2 (pl)
EP (1) EP2024748B1 (pl)
JP (1) JP2009540278A (pl)
KR (1) KR20090023372A (pl)
AU (1) AU2007256377B2 (pl)
CA (1) CA2654330A1 (pl)
DE (1) DE07725949T1 (pl)
DK (1) DK2024748T3 (pl)
ES (1) ES2396730T3 (pl)
PL (1) PL2024748T3 (pl)
PT (1) PT2024748E (pl)
RU (1) RU2467335C2 (pl)
WO (1) WO2007141043A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
CA2738032A1 (en) * 2008-09-26 2010-04-01 Proteosys Ag Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
WO2015035941A1 (en) * 2013-09-12 2015-03-19 The University Of Hong Kong Use of annexin a3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
US20030108963A1 (en) 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
ES2396730T3 (es) 2013-02-25
EP2024748B1 (en) 2012-12-12
RU2467335C2 (ru) 2012-11-20
WO2007141043A2 (en) 2007-12-13
KR20090023372A (ko) 2009-03-04
WO2007141043A3 (en) 2008-03-20
US20100233160A1 (en) 2010-09-16
AU2007256377A1 (en) 2007-12-13
DK2024748T3 (da) 2013-03-18
DE07725949T1 (de) 2009-07-02
RU2008152009A (ru) 2010-07-20
JP2009540278A (ja) 2009-11-19
PT2024748E (pt) 2013-01-16
US8012697B2 (en) 2011-09-06
EP2024748A2 (en) 2009-02-18
AU2007256377B2 (en) 2012-11-01
CA2654330A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
HRP20181565T1 (hr) Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma
ME02345B (me) MONOKLONSKA ANTlTELA PROTIV GLIPIKANA-3
IL196470A (en) Antagonist antibody for cancer treatment
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
IL193871A0 (en) Humanized anti-cd20 monoclonal antibody
EP2198055A4 (en) HUMANIZED PAI-1 ANTIBODIES
PL2024748T3 (pl) Przeciwciała monoklonalne przeciw aneksynie A3 do wykrywania raka gruczołu krokowego
PL2184605T3 (pl) Immunologiczny test podwójnego wiązania do detekcji przeciwciał
SI2024748T1 (sl) Monoklonska anti-aneksin A3 protitelesa za detekcijo karcinoma prostate